Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this trial is to determine if the administration of allogeneic MSCs at defined doses is safe in patients who are at high risk of developing significant Acute Kidney Injury (AKI) after undergoing on-pump cardiac surgery.
Epistemonikos ID: f983172db99bc07424b987495db62efa02e99634
First added on: May 05, 2024